WebOct 4, 2016 · GCGR inhibition also increased serum GLP-1 concentrations and insulin levels in pancreatic islets . Similar beneficial results of GCGR inhibition by GCGR ASO were largely confirmed in a different study . In all above-mentioned studies, no significant hypoglycemic effects were observed [8••,9••,14,59,60•]. Taken together, these proof ... WebGCGR ASO-treated db/db mice showed reduced plasma TG levels and increased hepatic TG contents (5, 6). In the current study, inhibition of GCGR by si-RNA demonstrated …
阿斯利康终止开发一款中后期GLP-1R/GCGR激动剂cotadutide
WebJul 1, 2004 · GCGR-ASO successfully reduced blood glucose levels in rodent models of diabetes, including ob/ob mice and ZDF rats 32 . GCGR-ASO also increased the plasma levels of glucagon and GLP-1 and induced ... WebHepatic glucose overproduction is a major characteristic of type 2 diabetes. Because glucagon is a key regulator for glucose homeostasis, antagonizing the glucagon receptor (GCGR) is a possible therapeutic strategy for the treatment of diabetes mellitus. To study the effect of hepatic GCGR inhibition on the regulation of lipid metabolism, we generated … life is a shipwreck quote
Effects of small interfering RNA-mediated hepatic …
WebJun 22, 2014 · Europe PMC is an archive of life sciences journal literature. Search life-sciences literature (41,088,775 articles, preprints and more) WebJun 22, 2014 · The α-cell hyperplasia may cause certain safety concerns but is transient after withdrawing the GCGR ASO. 48 Moreover, ISIS Pharmaceuticals recently reported the positive data from a phase 2 study of GCGR ASO based therapy as shown by the remarkable reductions in hemoglobin A1c (HbA1c) and the improvement in pancreatic … WebImportantly, GCGR ASO did not cause pancreatic alpha cell expansion or hyperplasia at any dose. In conclusion, this study demonstrates that reduction of hepatic GCGR expression … mcse study guide pdf free download